DOJ approves $69B CVS-Aetna merger with Part D divestiture

DOJ
Aetna's Part D divestiture satisfied antitrust regulators who approved the $69 billion deal with CVS Wednesday. (skpy/Flickr)

The Department of Justice (DOJ) approved a $69 billion CVS-Aetna merger on Wednesday after Aetna agreed to sell off its Part D business. 

The Part D divestiture was a condition of the merger's approval, according to the DOJ. Late last month, Aetna agreed to sell its 2.2 million Part D business to WellCare. 

RELATED: Aetna sells Part D plans to WellCare in a 'significant step' toward closing CVS deal